-
-
-
-
-
-
-
Evofem Biosciences (EVFM) Misses Q1 EPS by 8c
-
-
-
-
-
-
-
U.S. FDA Acknowledges Receipt of Evofem Biosciences' New Drug Application Resubmission for Amphora® for the Prevention of Pregnancy
-
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

